인쇄하기
취소
|
The pharmaceutical distribution industry is about to start rejecting GSK products handling since GSK products provide distribution cost less than the break-even point.
Up to now, the pharmaceutical distribution industry has focused on GSK among the multinational pharmaceutical companies and has requested continuously to increase distribution cost and accept credit card payment.
However, GSK h...